Hikma Pharmaceuticals plc Financials

Market Capitalization £4.63 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	29.77
Forward PE	11.71
Price to Sales TTM	£1.53
Price to Book MRQ	£202.15
Enterprise to Revenue	1.87
Enterprise to EBITDA	6.70

Financial Reports as of Jun. 30, 2019

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2019-06-30
Profit Margin	9.45%
Operating Margin	25.62%
Return on Assets TTM	9.40%
Return on Equity TTM	12.88%

Income Statement

Revenue TTM	£2,462,113,217
Revenue per Share TTM	£13.68
Quarterly Revenue Growth	10.00%
Gross Profit TTM	£1,181,683,796
EBITDA	£786,000,000
Net Income to Common TTM	£232,582,791
Diluted EPS TTM	£0.70
Quarterly Earnings Growth YoY	72.50%

Balance Sheet

Total Cash MRQ	£212,180,792
Total Cash per Share MRQ	£1.17
Total Debt MRQ	£
Total Debt to Equity MRQ	55.48
Current Ratio MRQ	1.66
Book Value per Share MRQ	£10.31

Cash Flow

Operating Cash Flow TTM	£476,590,702
Levered Free Cash Flow TTM	£334,898,824

HIK Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	221,884,992
Float Shares	155,327,524
Avg 10 Volume	345,577
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	29.92%
% Held by Institutions	37.97%

Stock Price Summary

Beta	0.44
Fifty Two Week Low	£1750.00
Fifty Two Week High	£2165.00
Fifty Two Week Change	10.99%
Day 50 MA	£1948.04
Day 200 MA	£1929.53

Dividends and Splits

Forward Annual Dividend Rate	£64.00
Forward Annual Dividend Yield	3.00%
Trailing Annual Dividend Rate	£79.00
Trailing Annual Dividend Yield	3.71%
Payout Ratio	72.75%
Dividend Date
Ex Dividend Date	2024-08-15
Last Split Factor
Last Split Date